AEON Biopharma
AEON
AEON
17 hedge funds and large institutions have $12M invested in AEON Biopharma in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Holders
17
Holding in Top 10
–
Calls
$566K
Puts
–
Top Buyers
| 1 | +$79.5K | |
| 2 | +$72.6K | |
| 3 | +$70.8K | |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$41.1K |
| 5 |
Walleye Capital
New York
|
+$15.8K |
Top Sellers
| 1 | -$1.69M | |
| 2 | -$1.07M | |
| 3 | -$1.01M | |
| 4 |
GCWM
Graham Capital Wealth Management
Washington D.c.,
District of Columbia
|
-$997K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$718K |